Near-Term Technology Development for Genome Sequencing (SBIR [R43/R44])

The summary for the Near-Term Technology Development for Genome Sequencing (SBIR [R43/R44]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Near-Term Technology Development for Genome Sequencing (SBIR [R43/R44]): -Purpose. The National Human Genome Research Institute (NHGRI) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop novel technologies that will substantially reduce the cost of genomic DNA sequencing. Current technologies are able to produce the sequence of a mammalian-sized genome of the desired data quality for $5 to $10 million; the goal of this initiative is to reduce costs by at least two orders of magnitude. As some technologies that have potential to achieve this goal are already in or near the commercial market, applications to this FOA will need to show clear advantage over current and emerging technologies. -Highest priority will be given to applications that either (1) propose new approaches that will outperform those being employed in the current next-generation sequencing technologies, or (2) address specific weaknesses or shortcomings in current methods. -Applicants may propose to develop full-scale sequencing systems, or to investigate key components of such systems. Such independent proposals are an important path for pursuing novel, high risk/high pay-off ideas.
Federal Grant Title: Near-Term Technology Development for Genome Sequencing (SBIR [R43/R44])
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HG-07-018
Type of Funding: Grant
CFDA Numbers: 93.172
CFDA Descriptions: Human Genome Research
Current Application Deadline: No deadline provided
Original Application Deadline: Nov 10, 2007
Posted Date: Sep 11, 2007
Creation Date: Sep 11, 2007
Archive Date: Dec 10, 2007
Total Program Funding: $2,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification) Small businesses
Additional Information on Eligibility
Foreign institutions are not eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed)
NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)
Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Op...
Research on the Impact of and Methods for Implementing Regional Genomic Medicine eConsult ...
Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44)
Near-Term Technology Development for Genome Sequencing - STTR (R41/R42)
Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com